284 related articles for article (PubMed ID: 27495762)
1. Graft Versus Host Disease After Liver Transplantation in Adults: A Case series, Review of Literature, and an Approach to Management.
Murali AR; Chandra S; Stewart Z; Blazar BR; Farooq U; Ince MN; Dunkelberg J
Transplantation; 2016 Dec; 100(12):2661-2670. PubMed ID: 27495762
[TBL] [Abstract][Full Text] [Related]
2. Chronic graft-versus-host disease after liver transplantation: a case report.
Yilmaz M; Ozdemir F; Akbulut S; Ersan V; Koc C; Koc S; Yilmaz S
Transplant Proc; 2012; 44(6):1751-3. PubMed ID: 22841262
[TBL] [Abstract][Full Text] [Related]
3. Acute graft-versus-host disease after liver transplant: novel use of etanercept and the role of tumor necrosis factor alpha inhibitors.
Thin L; Macquillan G; Adams L; Garas G; Seow C; Cannell P; Augustson B; Mitchell A; Delriveire L; Jeffrey G
Liver Transpl; 2009 Apr; 15(4):421-6. PubMed ID: 19326415
[TBL] [Abstract][Full Text] [Related]
4. Graft-versus-Host Disease after Liver Transplantation: A Single-Center Case Series.
Elsiesy H; Ibrahim A; Selim K; Al Sebayel M; Broering D; Al Hamoudi W; Al Arieh R; Abaalkhail F
Ann Transplant; 2015 Jul; 20():397-401. PubMed ID: 26169190
[TBL] [Abstract][Full Text] [Related]
5. Graft-versus-host disease after liver transplantation: a comprehensive literature review.
Akbulut S; Yilmaz M; Yilmaz S
World J Gastroenterol; 2012 Oct; 18(37):5240-8. PubMed ID: 23066319
[TBL] [Abstract][Full Text] [Related]
6. Graft-versus-host disease presenting with pancytopenia after en bloc multiorgan transplantation: case report and literature review.
Mawad R; Hsieh A; Damon L
Transplant Proc; 2009 Dec; 41(10):4431-3. PubMed ID: 20005417
[TBL] [Abstract][Full Text] [Related]
7. Incidence and risk factors of graft-versus-host disease after liver transplantation: A national study 2010-2020.
Huang Y; Wang Y; Chase RC; Yang L
Hepatol Commun; 2023 Oct; 7(10):. PubMed ID: 37756119
[TBL] [Abstract][Full Text] [Related]
8. Long-term outcome of patients undergoing liver transplantation for mixed hepatocellular carcinoma and cholangiocarcinoma: an analysis of the UNOS database.
Vilchez V; Shah MB; Daily MF; Pena L; Tzeng CW; Davenport D; Hosein PJ; Gedaly R; Maynard E
HPB (Oxford); 2016 Jan; 18(1):29-34. PubMed ID: 26776848
[TBL] [Abstract][Full Text] [Related]
9. Cytokine and human leukocyte antigen (HLA) profile for graft-versus-host disease (GVHD) after organ transplantation.
Chen X; Meng X; Xu Y; Xie H; Yin S; Li H; Wu L; Zheng S
Eur J Med Res; 2016 Oct; 21(1):38. PubMed ID: 27729070
[TBL] [Abstract][Full Text] [Related]
10. Graft-versus-host disease after liver transplantation complicated by systemic aspergillosis with pancarditis.
Romagnuolo J; Jewell LD; Kneteman NM; Bain VG
Can J Gastroenterol; 2000; 14(7):637-40. PubMed ID: 10978951
[TBL] [Abstract][Full Text] [Related]
11. Acute graft versus host disease following living donor liver transplantation: first Korean report.
Cho EH; Suh KS; Yang SH; Lee HW; Cho JY; Cho YB; Yi NJ; Lee KU
Hepatogastroenterology; 2007; 54(79):2120-2. PubMed ID: 18251173
[TBL] [Abstract][Full Text] [Related]
12. Late onset of severe graft-versus-host disease following liver transplantation.
Sun B; Zhao C; Xia Y; Li G; Cheng F; Li J; Zhang F; Wang X
Transpl Immunol; 2006 Nov; 16(3-4):250-3. PubMed ID: 17138062
[TBL] [Abstract][Full Text] [Related]
13. Solid-Organ Graft-Versus-Host Disease After Liver Transplant: A Case Report.
Auerbach JS; Schott CK
Crit Care Nurse; 2016 Jun; 36(3):e7-e11. PubMed ID: 27252108
[TBL] [Abstract][Full Text] [Related]
14. Treatment of graft-versus-host disease with mesenchymal cells as a complication of a liver transplantation.
Mora L; Alegre F; Rifón JJ; Martí P; Herrero JI
Rev Esp Enferm Dig; 2018 Nov; 110(11):734-736. PubMed ID: 30284904
[TBL] [Abstract][Full Text] [Related]
15. Detecting Donor-Derived DNA by Real-Time PCR in Recipients Suspected of Graft-Versus-Host-Diseases After Liver Transplantation: A Case Series and Literature Review.
Ha C; Kim SJ; Kim JM; Joh JW; Jang KT; Choi GS; Kang ES
Ann Transplant; 2023 Feb; 28():e938287. PubMed ID: 36840341
[TBL] [Abstract][Full Text] [Related]
16. Reduced exposure to calcineurin inhibitors early after liver transplantation prevents recurrence of hepatocellular carcinoma.
Rodríguez-Perálvarez M; Tsochatzis E; Naveas MC; Pieri G; García-Caparrós C; O'Beirne J; Poyato-González A; Ferrín-Sánchez G; Montero-Álvarez JL; Patch D; Thorburn D; Briceño J; De la Mata M; Burroughs AK
J Hepatol; 2013 Dec; 59(6):1193-9. PubMed ID: 23867318
[TBL] [Abstract][Full Text] [Related]
17. Benefit of Treating Hepatocellular Carcinoma Recurrence after Liver Transplantation and Analysis of Prognostic Factors for Survival in a Large Euro-American Series.
Sapisochin G; Goldaracena N; Astete S; Laurence JM; Davidson D; Rafael E; Castells L; Sandroussi C; Bilbao I; Dopazo C; Grant DR; Lázaro JL; Caralt M; Ghanekar A; McGilvray ID; Lilly L; Cattral MS; Selzner M; Charco R; Greig PD
Ann Surg Oncol; 2015 Jul; 22(7):2286-94. PubMed ID: 25472651
[TBL] [Abstract][Full Text] [Related]
18. Liver transplantation for hepatitis B virus: Decreasing indication and changing trends.
Al-Hamoudi W; Elsiesy H; Bendahmash A; Al-Masri N; Ali S; Allam N; Al Sofayan M; Al Bahili H; Al Sebayel M; Broering D; Saab S; Abaalkhail F
World J Gastroenterol; 2015 Jul; 21(26):8140-7. PubMed ID: 26185387
[TBL] [Abstract][Full Text] [Related]
19. Acute Graft-vs-Host Disease After Liver Transplantation: Experience at a High-volume Liver Transplantation Center in Korea.
Kang WH; Hwang S; Song GW; Jung DH; Park GC; Ahn CS; Moon DB; Kim KH; Ha TY; Kim WJ; Kim SH; Cho HD; Kwon JH; Jwa EK; Lee SG
Transplant Proc; 2016 Dec; 48(10):3368-3372. PubMed ID: 27931583
[TBL] [Abstract][Full Text] [Related]
20. Graft-versus-host disease after living donor liver transplantation: an unpredictable troublesome complication for liver transplant centers.
Gonultas F; Akbulut S; Barut B; Kutluturk K; Yilmaz S
Eur J Gastroenterol Hepatol; 2020 Jan; 32(1):95-100. PubMed ID: 31524772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
